Showing results (231-240 of 1,990) with videos related to
Sort By:
Pageof 199
Expert Review of Molecular Diagnostics|January 12, 2016
Histone modifying enzymes: novel disease biomarkers and assay developmentFei Ma, Chun-yang ZhangPhysical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 7, 2007
Failure of parameter identification based on adaptive synchronization techniquesWei Lin, Huan-Fei MaJournal of Healthcare Engineering|December 3, 2021
Application of Multislice Spiral CT Imaging Technology in the Diagnosis of Patients with Chest SarcoidosisHong-Fei Ma, Liang ChenInternational Journal of Cancer|June 27, 2019
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancerFei Ma, Yanfang Guan, Zongbi Yi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2019
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical TrialQiao Li, Xiuwen Guan, Shanshan Chen, et al.Breast (Edinburgh, Scotland)|December 14, 2020
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in ChinaYiqun Li, Qiao Li, Hongnan Mo, et al.Breast (Edinburgh, Scotland)|November 1, 2025
Associations between dynamic hematological indicators and outcomes in HR-positive, HER2-negative metastatic breast cancer treated with bireociclib or placebo plus fulvestrant: Findings from the BRIGHT-2 trialHangcheng Xu, Yan Wang, Qiang Sa, et al.The Oncologist|May 23, 2024
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in ChinaYing Fan, Danyang Ji, Mingxia Jiang, et al.Investigational New Drugs|May 12, 2023
Pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumorsYang Luo, Ying Cheng, Chunjiao Wu, et al.Cancer Chemotherapy and Pharmacology|March 20, 2019
Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumoursPeng Yuan, Jianzhong Shentu, Jianming Xu, et al.Pageof 199